In addition to our latest blogs on biosimilars from our sister site (www.biosimilarsrr.com), here is a sampling of recent publications and articles developed by SM Health Communications LLC, by category.

White Papers/Comprehensive Reports

Deep dives into focused topics, involving healthcare policy.

Mehr SR: The US Biosimilar Market: A History of Growth and Towards a Sustainable Future. January 2023 https://biosimilarsrr.com/our-biosimilars-market-report/.

Mehr SR: Where the US Biosimilars Market Is Heading and When It Might Get There, Eds 1 & 2. February 2020 and January 2021.

Mehr SR, Renfro M: The Patient’s Paramount Place: Emphasis on Empowerment, Engagement, Experience. Academy of Managed Care Pharmacy Foundation. August 2018.

Mehr SR, Reinert A: The Rx affordability crisis. Academy of Managed Care Pharmacy Foundation. September 2017.

Mehr SR: AMCP Market Insights: Focus on Psoriasis. American Medical Communications, Manalpan, NJ, June 2016.

The Biotechnology Monitor and Survey, Eds 1 & 2. Wayne, New Jersey, Emron, Inc, 2008 and 2009. 

I just wanted to drop you a note to say Thank you for taking the time to connect with my Director and I on the ‘state of biosimilars’ update! Your opinions, knowledge, and forward-looking perspectives were enlightening, and we truly learned a lot from speaking with you. I look forward to seeing more of your content in my news feed and following along on your posts and insights!

Tina Witte
Senior Associate Director
Fletcher Hospital and Healthcare Solutions

Articles Published

Papers appearing in peer-reviewed journals.

Mehr SR: Which Biosimilar Companies Will Thrive in 2025? Biosimilar Development March 31, 2020. https://www.biosimilardevelopment.com/doc/which-biosimilar-companies-will-thrive-in-0001.

Mehr SR, Brook RA:  Biosimilars in the USA: Will new efforts to spur approvals and access spur uptake and cost savings? Pharmaceutical Medicine 2019; https://doi.org/10.1007/s40290-018-00262-z.

Mehr SR: Can the FTC Clear a Path for Biosimilar Access Through the Patent Thicket? Biosimilar Development June 4, 2019. https://www.biosimilardevelopment.com/doc/can-the-ftc-clear-a-path-for-biosimilar-access-through-the-patent-thicket-0001.

Medicare’s International Pricing Index–Biosimilar Stakeholders Weigh In. Biosimilar Development February 19, 2019. https://www.biosimilardevelopment.com/doc/medicare-s-international-pricing-index-biosimilar-stakeholders-weigh-in-0001.

Mehr SR: If four-letter suffixes aren’t used in biosimilar tracking, what use are they? Biosimilar Development. November 6, 2018. https://www.biosimilardevelopment.com/doc/if-four-letter-suffixes-aren-t-used-in-biosimilar-tracking-what-use-are-they-0001.

Mehr SR: Will the PCSK9 inhibitors be employers’ “line in the sand”? Am Health Drug Benefits 2016;9(3):171-174.

Mehr SR: The Top 5 Health Benefits/Delivery Trends Affecting Oncology Business Practices. Oncology Practice Management 2016;2(6).

Mehr SR, Zimmerman MP: Reviewing the Unmet Needs in Multiple Sclerosis. Am Health Drug Benefits. 2015;8(8):426-431.

Radick L, Mehr SR: The Latest Innovations and the Phase 3 Pipeline for Multiple Sclerosis. Am Health Drug Benefits 2015;8(8):448-453.

Uncredited Works

Articles developed for on-line and print publishers without a byline.

Rett Syndrome. CheckRare February 6, 2023. https://checkrare.com/rett-syndrome/

Type 1 Galactosemia: Significant Unmet Need, Lifelong Complications, and Current Management. CheckRare March 30, 2022. https://checkrare.com/galactosemia-disease-resource-center/

Niemann-Pick Disease Type C. CheckRare November 17, 2020. https://checkrare.com/niemann-pick-disease-type-c/. 

Angelman Syndrome. CheckRare November 17, 2020. https://checkrare.com/angelman-syndrome/ 

Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. CheckRare November 17, 2020. https://checkrare.com/aromatic-l-amino-acid-decarboxylase-aadc-deficiency/. 

See our sister site Biosimilars Review & Reports  for postings on the rapidly changing biosimilar arena.